Disease name | Atherosclerosis |
---|---|
Classfication | Cardiovascular system disease |
Related Enzyme(s) | |
EFO | EFO:0003914 |
DOID | 1936 |
OMIM | |
NCI | |
Definition | Atherosclerosis is a disease in which the inside of an artery narrows due to the build of plaque. Initially there are generally no symptoms. When severe it can result in coronary artery disease, stroke, peripheral artery disease, or kidney problems depending on the arteries which are affected. Symptoms, if they occur, generally do not begin until middle age. |
Gene symbol | Species | Enzyme | Editing site(s) | Editing Type | PMID | RADAR | REDIportal | Description |
---|---|---|---|---|---|---|---|---|
CTSS | Human | ADAR1 | 41 | A-to-I | RNA-editing in the CTSS 3'UTR will knockdown the CTSS mRNA expression, and RNA-editing of CTSS mRNA also regulate the RNA-binding protein HuR, deficiency of cathepsin S reduces atherosclerosis and angiogenesis in vivo. And it will reduce the binding efficiency of HuR, which will lead to Decrease the stability of CTSS mRNA. |
Gene symbol | Disease | Enzyme | Editing Sites | Editing Type | miRBase | PMID | Description |
---|---|---|---|---|---|---|---|
hsa-mir-27b | - | 1 | A-to-I | MI0000440 | pri-mir-27b editing in aortic wall and internal mammary artery are associated with increased plasma levels of high-density lipoprotein | ||
hsa-miR-605 | - | 1 | A-to-I | MI0003618 | mir-605 editing in the aortic wall and internal mammary artery are associated with increased plasma levels of high-density lipoprotein. |